RU2001102491A - PHARMACEUTICAL SUSPENSION DRUG CONTAINING AMOXICILLINE, CLAVANIC ACID AND CELLULOSE - Google Patents

PHARMACEUTICAL SUSPENSION DRUG CONTAINING AMOXICILLINE, CLAVANIC ACID AND CELLULOSE

Info

Publication number
RU2001102491A
RU2001102491A RU2001102491/14A RU2001102491A RU2001102491A RU 2001102491 A RU2001102491 A RU 2001102491A RU 2001102491/14 A RU2001102491/14 A RU 2001102491/14A RU 2001102491 A RU2001102491 A RU 2001102491A RU 2001102491 A RU2001102491 A RU 2001102491A
Authority
RU
Russia
Prior art keywords
cellulose
paragraphs
drug according
preparation
active ingredients
Prior art date
Application number
RU2001102491/14A
Other languages
Russian (ru)
Other versions
RU2205639C2 (en
Inventor
Боян КОФЛЕР
Матея КОВАЦИЦ
Original Assignee
Лек Фармасьютикал энд Кемикал Ко. Д.Д.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815532.8A external-priority patent/GB9815532D0/en
Application filed by Лек Фармасьютикал энд Кемикал Ко. Д.Д. filed Critical Лек Фармасьютикал энд Кемикал Ко. Д.Д.
Publication of RU2001102491A publication Critical patent/RU2001102491A/en
Application granted granted Critical
Publication of RU2205639C2 publication Critical patent/RU2205639C2/en

Links

Claims (9)

1. Сухой порошковый препарат, адаптированный для разведения водой и содержащий амоксициллина тригидрат и клавуланат калия в качестве активных ингредиентов и целлюлозу в качестве наполнителя, причем этот препарат возможно дополнительно включает в себя один или более чем один фармацевтически приемлемый эксципиент, выбранный из: корригентов, подсластителей, буферных агентов, стабилизаторов и модификаторов вязкости.1. A dry powder preparation adapted for reconstitution with water and containing amoxicillin trihydrate and potassium clavulanate as active ingredients and cellulose as a filler, the preparation optionally further comprising one or more pharmaceutically acceptable excipients selected from: flavoring agents, sweeteners buffering agents, stabilizers and viscosity modifiers. 2. Препарат по п. 1, в котором целлюлоза выбрана из микрокристаллической целлюлозы, порошковой целлюлозы и их смесей. 2. The drug according to claim 1, in which the cellulose is selected from microcrystalline cellulose, powdered cellulose and mixtures thereof. 3. Препарат по п. 1 или 2, в котором количество целлюлозы составляет от 5 до 60% по массе сухого препарата. 3. The drug according to claim 1 or 2, in which the amount of cellulose is from 5 to 60% by weight of the dry preparation. 4. Препарат по любому из пп. 1-3, в котором количество активных ингредиентов составляет от 20 до 70% по массе сухого препарата. 4. The drug according to any one of paragraphs. 1-3, in which the amount of active ingredients is from 20 to 70% by weight of the dry preparation. 5. Препарат по любому из пп. 1-4, включающий в себя микрокристаллическую целлюлозу, имеющую размер частиц от 20 до 100 мкм, предпочтительно от 20 до 50 мкм. 5. The drug according to any one of paragraphs. 1-4, including microcrystalline cellulose having a particle size of from 20 to 100 microns, preferably from 20 to 50 microns. 6. Препарат по любому из пп. 1-5, включающий в себя микрокристаллическую целлюлозу, имеющую размер частиц 50 мкм. 6. The drug according to any one of paragraphs. 1-5, including microcrystalline cellulose having a particle size of 50 μm. 7. Препарат по любому из пп. 1-6, в котором указанные возможные дополнительные эксципиенты включают в себя один или более чем один сахар, не оказывающий слабительного действия. 7. The drug according to any one of paragraphs. 1-6, in which these possible additional excipients include one or more sugar, not having a laxative effect. 8. Разведенная водная суспензия или дисперсия, полученная из препарата по любому из пп. 1-7 и содержащая единицу дозировки активных ингредиентов в 5 мл. 8. A diluted aqueous suspension or dispersion obtained from the preparation according to any one of paragraphs. 1-7 and containing a unit dosage of active ingredients in 5 ml. 9. Применение препарата по любому из пп. 1-8 для лечения бактериальных инфекций у педиатрических и чувствительных взрослых пациентов. 9. The use of the drug according to any one of paragraphs. 1-8 for the treatment of bacterial infections in pediatric and sensitive adult patients.
RU2001102491/14A 1998-07-17 1999-07-15 Pharmaceutical suspension preparation containing amoxicillin, clavulanic acid and cellulose RU2205639C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9815532.8 1998-07-17
GBGB9815532.8A GB9815532D0 (en) 1998-07-17 1998-07-17 Pharmaceutical suspension formulation

Publications (2)

Publication Number Publication Date
RU2001102491A true RU2001102491A (en) 2002-11-27
RU2205639C2 RU2205639C2 (en) 2003-06-10

Family

ID=10835666

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001102491/14A RU2205639C2 (en) 1998-07-17 1999-07-15 Pharmaceutical suspension preparation containing amoxicillin, clavulanic acid and cellulose

Country Status (14)

Country Link
US (1) US6511972B1 (en)
EP (1) EP1098633A1 (en)
AU (1) AU762840B2 (en)
CZ (1) CZ296003B6 (en)
GB (1) GB9815532D0 (en)
HR (1) HRPK20010048B1 (en)
HU (1) HUP0103015A3 (en)
PL (1) PL194393B1 (en)
RU (1) RU2205639C2 (en)
SK (1) SK286339B6 (en)
UA (1) UA73720C2 (en)
WO (1) WO2000003695A1 (en)
YU (1) YU3101A (en)
ZA (1) ZA200100463B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69617036T2 (en) 1995-09-07 2002-07-11 Smithkline Beecham Corp., King Of Prussia USE OF A PEDIATRIC PHARMACEUTICAL FORMULATION CONTAINING AMOXICILLIN AND CLAVULANATE
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
GB2365337A (en) * 1999-04-13 2002-02-20 Beecham Pharma Amoxycillin and potassium clavulanate high dosage regimen
EA004310B1 (en) * 1999-04-13 2004-02-26 Бичам Фармасьютикалз (Пте) Лимитед Novel method of treatment
ATE334655T1 (en) * 1999-08-20 2006-08-15 Glaxosmithkline Lab Sas PHARMACEUTICAL FORMULATION CONTAINING AMOXICILLIN AND CLAVULANATE
FR2797588B1 (en) * 1999-08-20 2003-08-01 Smithkline Beecham Lab PHARMACEUTICAL FORMULATION BASED ON AMOXYCILLIN AND CLAVULANATE
SI20411A (en) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Watersoluble powders for peroral solution and their use
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
JP2004519463A (en) * 2001-01-23 2004-07-02 ガドール エス アー Composition for prevention and / or treatment of bone metabolic disease, method for preparing the composition and use thereof
CA2529102A1 (en) * 2003-06-16 2004-12-23 Glaxo Group Limited Pharmaceutical formulations comprising amoxicillin and clavulanate
EP1737449A1 (en) * 2004-03-01 2007-01-03 LEK Pharmaceuticals D.D. Pharmaceutical composition
TR201000687A1 (en) * 2010-01-29 2011-08-22 Bi̇lgi̇ç Mahmut Effervescent formulations containing cefixime and clavulanic acid as active ingredient
TR201000686A1 (en) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Water-soluble cefdinir and clavulanic acid formulations for the treatment of bacterial infections.
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
US9254261B2 (en) 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2028A1 (en) 1995-05-03 2002-10-23 Smithkline Beecham Plc Medicines used to treat bacterial infections in pediatrics.
WO1997006798A2 (en) * 1995-08-12 1997-02-27 Smithkline Beecham Plc Pharmaceutical formulations
AP1253A (en) * 1997-02-14 2004-03-17 Smithkline Beecham Laboratoires Pharmaceutiques Pharmaceutical formulations comprising amoxocyllin and clavulanate.
DE19706978A1 (en) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Combination preparation for oral antibiotics

Similar Documents

Publication Publication Date Title
RU2001102491A (en) PHARMACEUTICAL SUSPENSION DRUG CONTAINING AMOXICILLINE, CLAVANIC ACID AND CELLULOSE
CA2019863C (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
ES2237121T3 (en) FAST DISGREGABLE SOLID PREPARATION.
JP5202856B2 (en) Granular solid formulation containing tosfloxacin tosylate
JP6092629B2 (en) Suspension prepared for use with rifaximin
KR100979328B1 (en) Coated particulate cefuroxime axetil compositions
JP2016505022A (en) Honey nose cleaner
MXPA03008056A (en) Taste masked liquid pharmaceutical compositions.
JPH0248525B2 (en)
EA001878B1 (en) Method for treatment of bacterial infection in children
RU2205639C2 (en) Pharmaceutical suspension preparation containing amoxicillin, clavulanic acid and cellulose
WO2001026691A1 (en) Medicinal compositions for oral use
JP2002543160A (en) Pharmaceutical prescription
CN101756982B (en) Artesunate compound medicine composition with improved mouth feeling and high stability
JP5799062B2 (en) Granular solid formulation containing tosufloxacin
JP5799061B2 (en) Granular solid formulation containing tosufloxacin and polyvinylpyrrolidone
KR20050109077A (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetic acid
RU2005138127A (en) PHARMACEUTICAL PRODUCTS CONTAINING AMOXICILLIN AND CLAVULANATE
JP2006522089A (en) Taste masking vehicle for coated oxazolidinone particles
IE902109A1 (en) Anhydrous oil-based liquid suspension for delivering a¹medicament
KR102145022B1 (en) Suspension composition and dosage form of ibuprofen
CN116916892A (en) Anti-infective dosage forms for the production of nasal washes
US20230364038A1 (en) Anti-infective dosage forms for producing a nasal rinse
KR20030027422A (en) A pharmaceutical composition for taste-making cefuroxime axetil and preparation method of thereof
SI20058A (en) Pharmaceutical forms